Cyclosporine For The Treatment Of COVID-19(+)

NCT04492891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

SARS (Disease)

Interventions

DRUG: Cyclosporine
OTHER: Standard of Care Treatment

Sponsor

Bryan Burt, MD

Collaborators

[object Object]